Tuffclassified

Randomised Controlled Trials (RCTs), particularly Phase III clinical trials, have long been considered the gold standard in medical research. They provide the foundational data required for regulatory approval, demonstrating that a new therapy is both safe and efficacious under strictly controlled conditions. However, the journey of a pharmaceutical product does not end with regulatory approval. In fact, understanding how a treatment performs in the general population begins only after it enters the market. This is where Real World Evidence Studies become indispensable.